This innovative marijuana stock is taking a big step

There is a lot of investor demand for marijuana stocks right now. With the recent opening of the Canadian recreational cannabis market, as well as the growing number of US states and other jurisdictions legalizing the pot, companies that grow marijuana have become the stars. The desire to be able to invest in cannabis has prompted many companies to look at initial public offerings, both in Canada and on US stock exchanges.

<p class = "web-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "It could seem that marijuana growers are essentially identical, All share the growing demand for their products, but this is in fact not the case, as some companies have adopted innovative approaches to growing and harvesting cannabis, which he hopes will translate into better yields and lower costs. CannTrust Holdings (NASDAQOTH: CNTTF)and, soon, US investors will be able to buy shares of the Canadian farmer on the NYSE. "data-reactid =" 12 "> It could seem that marijuana growers are essentially the same, as the growing demand is shared between them – in reality, this is not the case as some companies have adopted innovative approaches. in terms of growing and harvesting cannabis, which investors hope will lead to better yields and lower costs. CannTrust Holdings (NASDAQOTH: CNTTF)and, soon, US investors will have the opportunity to buy shares of the Canadian farmer on the NYSE.

More

Source of the image: CannTrust.

What distinguishes CannTrust?

At first glance, CannTrust Holdings looks pretty much like any other marijuana company. The Canadian cannabis producer, headquartered in Vaughan, a suburb of Toronto, began as a specialist in the supply of marijuana products for medical purposes. The company owns two major growth facilities, one in Vaughan and the other in the Niagara region, on the other side of the border with Buffalo. With the recent legalization of recreational cannabis products, CannTrust has also expanded its field of action to serve the adult market.

CannTrust is far from the only company to launch medical cannabis, but it stands out in many ways. First, although the company began operations less than five years ago, its founders were pharmacists, bringing over 40 years of experience in the broader areas of pharmacy and health. This has allowed CannTrust to focus on science and the company remains committed to research and development with innovative products and production methods designed to help patients more easily achieve favorable marijuana results for medical purposes. With a pharmaceutical partner, CannTrust's product development teams are engaged in fact-based research that has spurred industry progress.

CannTrust's innovation research has been successful with a growing method that most major cannabis producing companies have not used. CannTrust's production facilities use state-of-the-art hydroponic technology to ensure a steady flow of high quality, completely pesticide-free standardized cannabis products. The company's original 50,000-square-foot facility includes cannabis cultivation capabilities as well as processing extracts such as cannabis-derived oils and product distribution to customers. Niagara's much larger facility, with an area of ​​430,000 square feet, utilizes state-of-the-art, continuously growing technology, with even greater prospects for improving returns.

How CannTrust Behaved

Until now, CannTrust's efforts seem to be paying off. In his third quarter financial report, the Canadian farmer reported a turnover of 12.6 million Canadian dollars, more than double the figures of the previous year, and the number of active patients treated CannTrust has exceeded the 50,000 mark. CannTrust has reported modest earnings of C $ 421,000, although these figures include substantial upward adjustments to changes in the fair value of biological assets.

The story continues